Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: An optical imaging study

Neuropathology

Volumn 32, Issue 3, 2012, Pages 217-226

  Kawabori, Masahito ^a   Kuroda, Satoshi ^a   Sugiyama, Taku ^a   Ito, Masaki ^a   Shichinohe, Hideo ^a   Houkin, Kiyohiro ^a   Kuge, Yuji ^b   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bone marrow stromal cell; Cell delivery; Cerebral infarct; Optical imaging; Transplantation

Indexed keywords

QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW STROMAL CELL TRANSPLANTATION; BRAIN INFARCTION; CELL TRANSPLANTATION; CONVALESCENCE; ENGRAFTMENT; FLUORESCENCE IMAGING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, NUCLEAR; BEHAVIOR, ANIMAL; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BRAIN; CELLS, CULTURED; CEREBRAL INFARCTION; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; MALE; MOVEMENT; NERVE TISSUE PROTEINS; PHENOTYPE; QUANTUM DOTS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, NEAR-INFRARED; STEREOTAXIC TECHNIQUES; STROMAL CELLS;

EID: 84857723585     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01260.x     Document Type: Article

References (48)

1. Dharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci 2009; 16: 12-20.
2. Chopp M, Steinberg GK, Kondziolka D etal. Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant 2009; 18: 691-693.
3. Kuroda S, Shichinohe H, Houkin K, Iwasaki Y. Autologous bone marrow stromal cell transplantation for central nervous system disorders - recent progress and perspective for clinical application. J Stem Cell Regen Med 2011; 7: 1-12.
4. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007; 40: 609-619.
5. Hokari M, Kuroda S, Shichinohe H, Yano S, Hida K, Iwasaki Y. Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. J Neurosci Res 2008; 86: 1024-1035.
6. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874-882.
7. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010; 28: 1099-1106.
8. Mendonca ML, Freitas GR, Silva SA etal. [Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke]. Arq Bras Cardiol 2006; 86: 52-55.
9. Bakshi A, Hunter C, Swanger S, Lepore A, Fischer I. Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique. J Neurosurg Spine 2004; 1: 330-337.
10. Jendelova P, Herynek V, DeCroos J etal. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med 2003; 50: 767-776.
11. Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine (Phila Pa 1976) 2009; 34: 328-334.
12. Vaquero J, Zurita M, Oya S, Santos M. Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration? Neurosci Lett 2006; 398: 129-134.
13. Borlongan CV, Chopp M, Steinberg GK etal. Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med 2008; 3: 249-250.
14. Lee JB, Kuroda S, Shichinohe H etal. A pre-clinical assessment model of rat autogeneic bone marrow stromal cell transplantation into the central nervous system. Brain Res Brain Res Protoc 2004; 14: 37-44.
15. Sugiyama T, Kuroda S, Osanai T etal. Near-infrared fluorescence labeling allows noninvasive tracking of bone marrow stromal cells transplanted into rat infarct brain. Neurosurgery 2011; 68: 1036-1047; discussion 47.
16. Lee JB, Kuroda S, Shichinohe H etal. Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice. Neuropathology 2003; 23: 169-180.
17. Shichinohe H, Kuroda S, Sugiyama T etal. Biological features of human bone marrow stromal cells (hBMSC) cultured with animal protein-free medium - safety and efficacy of clinical use for neurotransplantation. Transl Stroke Res 2011 (in press).
18. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-476.
19. Hokari M, Kuroda S, Chiba Y, Maruichi K, Iwasaki Y. Synergistic effects of granulocyte-colony stimulating factor on bone marrow stromal cell transplantation for mice cerebral infarct. Cytokine 2009; 46: 260-266.
20. Maruichi K, Kuroda S, Chiba Y etal. Transplanted bone marrow stromal cells improves cognitive dysfunction due to diffuse axonal injury in rats. Neuropathology 2009; 29: 422-432.
21. Shichinohe H, Kuroda S, Lee JB etal. In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Res Brain Res Protoc 2004; 13: 166-175.
22. Shichinohe H, Kuroda S, Sugiyama T, Ito M, Kawabori M. Bone marrow stromal cell transplantation attenuates cognitive dysfunction due to chronic cerebral ischemia in rats. Dement Geriatr Cogn Disord 2010; 30: 293-301.
23. Shichinohe H, Kuroda S, Yano S, Hida K, Iwasaki Y. Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct. Brain Res 2007; 1183: 138-147.
24. Shichinohe H, Kuroda S, Yano S etal. Improved expression of gamma-aminobutyric acid receptor in mice with cerebral infarct and transplanted bone marrow stromal cells: an autoradiographic and histologic analysis. J Nucl Med 2006; 47: 486-491.
25. Yano S, Kuroda S, Shichinohe H, Hida K, Iwasaki Y. Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct? - a double labeling study. Brain Res 2005; 1065: 60-67.
26. Chen J, Li Y, Wang L etal. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32: 1005-1011.
27. Li Y, Chen J, Zhang CL etal. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005; 49: 407-417.
28. Sugiyama T, Kuroda S, Takeda Y etal. Therapeutic impact of human bone marrow stromal cells expanded by animal serum-free medium for cerebral infarct in rats. Neurosurgery 2011; 68: 1733-1742.
29. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A Semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10: 290-293.
30. de Vasconcelos Dos Santos A, da Costa Reis J, Diaz Paredes B etal. Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 2010; 1306: 149-158.
31. Borlongan CV, Evans A, Yu G, Hess DC. Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res 2005; 1048: 116-122.
32. Shen LH, Li Y, Chen J etal. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007; 27: 6-13.
33. Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK. Intravascular cell replacement therapy for stroke. Neurosurg Focus 2008; 24: E15.
34. Hicks A, Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol Exp (Wars) 2009; 69: 1-11.
35. Li Y, Chen J, Chen XG etal. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002; 59: 514-523.
36. Chen X, Katakowski M, Li Y etal. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 2002; 69: 687-691.
37. Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 329-340.
38. Toyama K, Honmou O, Harada K etal. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 2009; 216: 47-55.
39. Son BR, Marquez-Curtis LA, Kucia M etal. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006; 24: 1254-1264.
40. Bakshi A, Fisher O, Dagci T, Himes BT, Fischer I, Lowman A. Mechanically engineered hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord injury. J Neurosurg Spine 2004; 1: 322-329.
41. Lundberg J, Le Blanc K, Soderman M, Andersson T, Holmin S. Endovascular transplantation of stem cells to the injured rat CNS. Neuroradiology 2009; 51: 661-667.
42. Fischer UM, Harting MT, Jimenez F etal. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009; 18: 683-692.
43. Michalet X, Pinaud FF, Bentolila LA etal. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307: 538-544.
44. Liebert A, Wabnitz H, Obrig H etal. Non-invasive detection of fluorescence from exogenous chromophores in the adult human brain. Neuroimage 2006; 31: 600-608.
45. Steinbrink J, Liebert A, Wabnitz H etal. Towards noninvasive molecular fluorescence imaging of the human brain. Neurodegener Dis 2008; 5: 296-303.
46. Lin S, Xie X, Patel MR etal. Quantum dot imaging for embryonic stem cells. BMC Biotechnol 2007; 7: 67.
47. Noh YW, Lim YT, Chung BH. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J 2008; 22: 3908-3918.
48. The STEPS Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009; 40: 510-515.